Healthcare Medical Devices Biotechnology

Taxifolin Market Report Cover

Taxifolin Market

Taxifolin Market Report Cover

Taxifolin Market Size, Share, Growth & Industry Analysis, By Purity (Less than 95%, More than or Equal to 95%), By Application (Food & Beverages, Pharmaceuticals, Agriculture, Cosmetics and Personal Care), and Regional Analysis, 2024-2031

Author : Swati J.


Pages : 120

Base Year : 2023

Release : October 2024

Report ID: KR1109


Taxifolin Market Size 

Global Taxifolin Market size was recorded at USD 88.4 million in 2023, which is estimated to be valued at USD 93.0 million in 2024 and is projected to reach USD 140.3 million by 2031, growing at a CAGR of 6.05% from 2024 to 2031.

The market is expanding due to increasing awareness of its health benefits, including its antioxidant, anti-inflammatory, and cardiovascular protective properties. The growing use of dietary supplements, functional foods, and pharmaceuticals is further driving demand. Additionally, the growing consumer preference for natural ingredients and clean-label products is increasing taxifolin's appeal, contributing significantly to market growth.

In the scope of work, the report includes solutions offered by companies such as Ametis JSC, Blue California, Biosynth, Cayman Chemical, Adooq Bioscience LLC., Robios Llc, Creative Enzymes, BOC Sciences, Linjiang Jianwei Biotech Co., Ltd., Merck KGaA, and others.

The taxifolin market is experiencing significant growth, fueled by its valued anti-aging and skin-protecting benefits in the cosmetic industry. Consumer demand for natural and effective skincare solutions is fueling the incorporation of taxifolin into personal care products such as creams, serums, and lotions.

Its strong antioxidant and anti-inflammatory benefits make it an ideal ingredient for protecting skin against environmental damage such as UV rays and pollution. This rising interest in natural ingredients, along with taxifolin's proven efficacy in skincare, is expected to stimulate market expansion in the forthcoming years.

Taxifolin, also known as dihydroquercetin, is a natural flavonoid found in various plant sources, particularly in Siberian larch and certain fruits and vegetables. Known for its potent antioxidant and anti-inflammatory properties, taxifolin plays a key role in neutralizing free radicals, protecting cells from oxidative stress, and supporting cardiovascular health.

It is widely used in dietary supplements, cosmetics, and pharmaceuticals for its health-promoting benefits. Additionally, taxifolin has been studied for its potential to improve skin health, reduce aging effects, and boost immune function, making it valuable in various industries focused on wellness and natural remedies.

Analyst’s Review

The rising application of taxifolin in pharmaceuticals is expected to boost market growth, with the segment projected to grow at a CAGR of 6.54%, according to our analysis. Taxifolin’s potent antioxidant, anti-inflammatory, and cardiovascular benefits are fueling its demand in drug formulations for chronic conditions.

Pharmaceutical companies can explore new applications for taxifolin by investing in research and development. Key players can capitalize on this opportunity by expanding product portfolios, enhancing formulations, and forming strategic partnerships with nutraceutical and healthcare sectors. These efforts are likely to increase product visibility and capture a larger market share, thereby augmenting further growth.

Taxifolin Market Growth Factors

Increasing consumer awareness of the health benefits of natural ingredients is leading to increased demand for taxifolin, particularly in dietary supplements and functional foods. With its strong antioxidant properties, taxifolin is emerging as a preferred choice for consumers looking for alternatives to synthetic additives.

Taxifolin is recognized for its support of cardiovascular health, enhancement of immune function, and the ability to combat oxidative stress, making it appealing to health-conscious individuals. This growing trend is prompting food, beverage, and nutraceutical companies to incorporate taxifolin into their product lines, expanding its market applications and contributing to its rising popularity in the wellness and functional food sectors.

The taxifolin market faces challenges due to fluctuating raw material availability and high extraction costs, which may hinder production and affect pricing. Additionally, a lack of awareness among consumers regarding taxifolin's benefits compared to more established ingredients may limit its market penetration. These challenges create barriers for companies seeking to expand their offerings and reach new customers.

To mitigate these challenges, key players are investing in sustainable sourcing practices to ensure a stable supply of raw materials and stabilize costs. Moreover, they are enhancing consumer education efforts through marketing campaigns that highlight taxifolin's health benefits and applications. Collaborations with research institutions are facilitating innovation in extraction techniques, leading to cost reductions and improved product quality. These factors are expected to augment the expansion of the market over the forecast period.

Taxifolin Market Trends

There is a growing trend toward sourcing taxifolin through sustainable and eco-friendly methods, supported by increasing consumer demand for environmentally responsible products. Companies are prioritizing responsible harvesting practices to ensure that taxifolin is derived from renewable sources and does not harm ecosystems.

Moreover, the implementation of environmentally friendly extraction processes reduces the carbon footprint and minimizes waste. This commitment to sustainability appeals to health-conscious consumers and aligns with global efforts to promote environmental conservation. The taxifolin market is experiencing significant growth, as brands that emphasize sustainability are attracting a larger customer base and gaining a competitive edge.

Increased investment in research and development is fostering innovations in taxifolin applications and formulations. Researchers are exploring new delivery methods, such as encapsulation and nanoformulations, to enhance its bioavailability and effectiveness. This has broadened taxifolin's utility across various industries, including pharmaceuticals, nutraceuticals, and food sectors.

In pharmaceuticals, taxifolin is being studied for its potential in treating cardiovascular diseases and inflammation. In the nutraceutical and food industries, it is being incorporated into functional foods and supplements. These advancements are expanding the reach of taxifolin, increasing consumer interest and promoting market growth.

Segmentation Analysis

The global market has been segmented based on purity, application, and geography.

By Purity

Based on purity, the market has been categorized into less than 95% and more than or equal to 95%. The more than or equal to 95% segment garnered the highest revenue of USD 51.4 million in 2023.

Products with this purity level are sought after for their potent antioxidant and anti-inflammatory properties, making them ideal for advanced formulations. In the pharmaceutical industry, high-purity taxifolin is preferred for producing cardiovascular drugs, anti-cancer treatments, and liver protection supplements. Increasing awareness regarding clean-label products in the nutraceuticals sector is further boosting demand.

Key players are leveraging this purity standard to differentiate their offerings and meet stringent regulatory requirements. This segment is expected to witness robust growth in the upcoming years due to increasing consumer demand for high-quality, scientifically-backed ingredients.

By Application

Based on application, the market has been categorized into food & beverages, pharmaceuticals, agriculture, and cosmetics and personal care. The pharmaceuticals segment captured the largest share of 42.21% in 2023, primarily fueled by its expanding use in drug formulations for cardiovascular health, cancer treatment, and liver protection.

Taxifolin's potent antioxidant, anti-inflammatory, and anti-tumor properties make it an important ingredient in the development of innovative pharmaceuticals. Ongoing clinical research demonstrates its effectiveness in reducing oxidative stress and protecting cells, leading to surging demand. With growing consumer interest in natural, bioactive compounds, the pharmaceutical sector is seeing increased application of taxifolin. Companies are investing in research to leverage taxifolin's therapeutic potential, thereby boosting segmental growth.

Taxifolin Market Regional Analysis

Based on region, the global market has been classified into North America, Europe, Asia-Pacific, MEA, and Latin America.

Taxifolin Market Size & Share, By Region, 2024-2031

Asia-Pacific taxifolin market accounted for the largest revenue share of 36.58% in 2023, with a valuation of USD 32.3 million. This growth is largely attributed to the rising consumer demand for natural health supplements, functional foods, and personal care products.

Countries such as China, Japan, and South Korea are experiencing increased awareness regarding the antioxidant and anti-inflammatory properties of taxifolin, making it a popular ingredient in pharmaceuticals and cosmetics. The growing focus on preventive healthcare, particularly in China and India, is further expanding the use of taxifolin in nutraceuticals.

Moreover, Asia-Pacific’s robust pharmaceutical and cosmetic manufacturing sector is fostering innovation in taxifolin-based products, creating potential opportunities for the expansion of the Asia-Pacific market.

Europe is anticipated to witness significant growth at a CAGR of 6.29% over the forecast period. This growth is propelled by the region's strong focus on natural ingredients and sustainable products, particularly in the cosmetics and personal care sectors.

Countries such as Germany, France, and the United Kingdom are experiencing rising consumer demand for eco-friendly and plant-based skincare solutions, where taxifolin's anti-aging and antioxidant properties are highly valued.

Additionally, European pharmaceutical companies are leveraging taxifolin’s health benefits in developing natural therapies, thus enhancing its market presence. The region’s stringent regulations on synthetic additives in food and cosmetics promote the use of taxifolin, facilitating the growth of the Europe taxifolin market.

Competitive Landscape

The global taxifolin market report will provide valuable insight with an emphasis on the fragmented nature of the industry. Prominent players are focusing on several key business strategies such as partnerships, mergers and acquisitions, product innovations, and joint ventures to expand their product portfolio and increase their market shares across different regions.

Companies are implementing impactful strategic initiatives, such as expanding services, investing in research and development (R&D), establishing new service delivery centers, and optimizing their service delivery processes, which are likely to create new opportunities for market growth.

List of Key Companies in Taxifolin Market

  • Ametis JSC
  • Blue California
  • Biosynth.
  • Cayman Chemical
  • Adooq Bioscience LLC. 
  • Robios Llc
  • Creative Enzymes
  • BOC Sciences
  • Linjiang Jianwei Biotech Co., Ltd.
  • Merck KGaA

The global taxifolin market is segmented as:

By Purity

  • Less than 95%
  • More than or Equal to 95%

By Application

  • Food & Beverages
  • Pharmaceuticals
  • Agriculture
  • Cosmetics and Personal Care

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • UK
    • Spain
    • Germany
    • Italy
    • Russia
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Rest of Asia-Pacific
  • Middle East & Africa
    • GCC
    • North Africa
    • South Africa
    • Rest of Middle East & Africa
  • Latin America
    • Brazil
    • Argentina
    • Rest of Latin America
CHOOSE LICENCE TYPE
CUSTOMIZATION OFFERED
  • Check Icon Additional Company Profiles
  • Check Icon Additional Countries
  • Check Icon Cross Segment Analysis
  • Check Icon Regional Market Dynamics
  • Check Icon Country-Level Trend Analysis
  • Check Icon Competitive Landscape Customization
  • Check Icon Extended Forecast Years
  • Check Icon Historical Data Up to 5 Years
Frequently Asked Questions (FAQ's)
The global market is projected to reach USD 140.3 million by 2031, growing at a CAGR of 6.05% from 2024 to 2031.
The global market was valued at USD 88.4 million in 2023.
The market is driven by rising consumer demand for natural antioxidants in dietary supplements and the increasing use of taxifolin in pharmaceuticals for its anti-inflammatory properties.
Top key players in market are Ametis JSC, Blue California, Biosynth, Cayman Chemical, Adooq Bioscience LLC., Robios Llc, Creative Enzymes, BOC Sciences, Linjiang Jianwei Biotech Co., Ltd., Merck KGaA, and others.
Asia-Pacific is the fastest growing region with the CAGR of 6.57% in the forecasted period (2024-2031) with the market value forecasted to reach at USD 53.3 million in 2031.
By purity, more than or equal to 95% segment will hold the maximum share in the market with the revenue value of USD 83.3 million in 2031. 
Get the latest!

Get actionable strategies to empower your business and market domination

  • Deliver Revenue Impact
  • Demand Supply Patterns
  • Market Estimation
  • Real-Time Insights
  • Market Intelligence
  • Lucrative Growth Opportunities
  • Micro & Macro Economic Factors
  • Futuristic Market Solutions
  • Revenue-Driven Results
  • Innovative Thought Leadership